Companies: 10,795·Total market cap: $144.5T
Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

NRIXNASDAQHealthcare● Active
$14.64
$-0.64(-4.19%)
Market Cap$1.3B
P/E Ratio
52W High$22.5
52W Low$8.195
Overview

Nurix Therapeutics, Inc. (NRIX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NRIX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.16nrix eps ttm · nrix earnings per shareEarnings history
PE Ratio (TTM)nrix pe ratio ttm · nrix price to earningsPE Ratio deep dive
Revenue (TTM)$71.8Mnrix revenue ttm · nrix annual revenueFull revenue history
Dividend YieldNo Dividenddoes nrix pay dividends · nrix dividend yieldDividend history
Shares Outstanding86.7Mnrix shares outstanding · nrix floatShares outstanding history
Next EarningsJul 9, 2026Est.nrix earnings date · nrix next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$84.0M▲ +53.95% YoY
202320242025
nurix therapeutics, inc. revenue · nrix revenue 2025
FY 2025Net Income-$264.5M▼ 36.62% YoY
202320242025
nurix therapeutics, inc. net income · nrix profit 2025
FY 2025EPS$-3.05▼ 5.90% YoY
202320242025
nrix eps · nurix therapeutics, inc. earnings per share 2025
TTM:Revenue: $71.8MNet Income: -$295.3MEPS: $-3.16View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy17 analystsis nrix a buy · nrix analyst rating
Strong Buy
0
Buy
17
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$28.00Low
$14.64Current
$32.20Avg Target119.95% upside
$36.00High
nrix price target · nrix 12 month forecast

Total: 17 · Buy rate: 100.0%

The NRIX analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $32.20, representing +119.95% upside from the current price of $14.64.

Stock Performance

Full History
1D-4.19%
1W-10.24%
1M-11.38%
3M-3.05%
YTD-22.83%
1Y+16.75%
5Y-53.67%

About Nurix Therapeutics, Inc.

CEOArthur T. Sands
IPO DateJul 24, 2020
Employees286
CountryUS

Nurix Therapeutics, Inc. a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The co…

what is nurix therapeutics, inc. · nrix stock overview · nurix therapeutics, inc. company profile · who is nurix therapeutics, inc. ceo · nrix NASDAQ · nurix therapeutics, inc. headquarters · nurix therapeutics, inc. business segments

About Stock Overview & Key Data

Nurix Therapeutics, Inc. (NRIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2020. As of the latest trading session, NRIX stock price is $14.64, with a market capitalization of $1.3B. The stock has returned +16.75% over the past 12 months and -22.83% year-to-date.

According to 17 Wall Street analysts, the consensus rating for Nurix Therapeutics, Inc. stock is Buy, with an average 12-month price target of $32.20. In fiscal year 2025, Nurix Therapeutics, Inc. reported revenue of $84.0M and net income of -$264.5M. For detailed data — including Nurix Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Nurix Therapeutics, Inc. (NRIX) stock price is $14.64. The stock is traded on NASDAQ under the ticker symbol NRIX. The 52-week range is $8.20 – $22.50.

NRIX stock priceNRIX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice